Research programme: glucagon-like peptide-1 long-acting - PROLOR Biotech

Drug Profile

Research programme: glucagon-like peptide-1 long-acting - PROLOR Biotech

Alternative Names: GLP-1-CTP; MOD-1001

Latest Information Update: 08 Jun 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Modigene
  • Developer PROLOR Biotech
  • Class Biological proteins; Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 08 Jun 2010 This programme is still in active development
  • 18 Jul 2007 Preclinical trials in Type-2 diabetes mellitus in Israel (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top